Literature DB >> 11761264

Safety of recombinant adenoviruses produced on adenovirus-transformed human cells.

F J Fallaux1, R C Hoeben.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11761264

Source DB:  PubMed          Journal:  Dev Biol (Basel)        ISSN： 1424-6074


× No keyword cloud information.
  3 in total

1.  Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.

Authors:  V Ann Stewart; Shannon M McGrath; Patrice M Dubois; Maria G Pau; Pascal Mettens; Joseph Shott; Michelle Cobb; J Robert Burge; David Larson; Lisa A Ware; Marie-Ange Demoitie; Gerrit Jan Weverling; Babak Bayat; Jerome H H V Custers; Marie-Claude Dubois; Joe Cohen; Jaap Goudsmit; D Gray Heppner
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

Review 2.  Gene therapy in The Netherlands: highlights from the Low Countries.

Authors:  Ellen A M Schenk-Braat; Leonie C M Kaptein; Marcella M Hallemeesch; Chris H Bangma; Rob C Hoeben
Journal:  J Gene Med       Date:  2007-10       Impact factor: 4.565

3.  293 cells express both epithelial as well as mesenchymal cell adhesion molecules.

Authors:  Masakazu Inada; Genya Izawa; Wakako Kobayashi; Masayuki Ozawa
Journal:  Int J Mol Med       Date:  2016-04-18       Impact factor: 4.101
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.